Neurocrine Biosciences, Inc. (0K6R.L) LSE

143.08

-1.92(-1.32%)

Updated at September 08 06:17PM

Currency In USD

Valuation

Market Cap13.7B
Enterprise Value13.93B
P/E Ratio40.96
PEG Ratio2.76
Price/Sales Ratio5.69
Price/Book Ratio5.29
Enterprise/Revenue5.76
Enterprise/EBITDA25.88

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin0.14
Operating Margin0.2

Management Effectiveness

Return On Assets0.09
Return On Equity0.13

Income Statement

Revenue2.36B
Revenue/Share25.35
Gross Profit2.32B
EBITDA639.7M
Net Income341.3M
Diluted EPS3.29

Balance Sheet

Total Cash975.6M
Total Cash/Share9.85
Total Debt439.1M
Total Debt/Equity0.16
Current Ratio3.2
Book Value Per Share27.22

Price History

52-Week Change20.12
52-Week High145.31
52-Week Low89.66
Moving Average 50 Days135.58
Moving Average 200 Days114.15

Statistics

Average Volume1,189
Shares Outstanding99.18M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A